FY22 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Solicitation (Updated)
- Updated Published Date: Jan 07, 2022 11:25 am EST
- Original Published Date: Nov 10, 2021 11:48 am EST
- Updated Date Offers Due: Jan 21, 2022 05:00 pm EST
- Original Date Offers Due: Jan 21, 2022 05:00 pm EST
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Feb 05, 2022
- Original Inactive Date: Feb 05, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Place of Performance: Silver Spring , MD 20993USA
Description
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
*This announcement is a renewal of the prior-year FY21 announcement (FDABAA-21-00123) and will remain open until further notice. This announcement is renewed on an annual basis.
Attachments/Links
Contact Information
Contracting Office Address
- 4041 Powder Mill Road 4th Floor
- Beltsville , MD 20705
- USA
Primary Point of Contact
- Robert Maydwell
- Robert.Maydwell@fda.hhs.gov
- Phone Number 301-348-1814
Secondary Point of Contact
- Terry Frederick
- Terry.Frederick@fda.hhs.gov
History
- Sep 30, 2022 11:56 pm EDTSolicitation (Updated)
- Jan 07, 2022 11:25 am ESTSolicitation (Updated)
- Jan 07, 2022 09:07 am ESTSolicitation (Updated)
- Nov 10, 2021 04:31 pm ESTSolicitation (Updated)
- Nov 10, 2021 11:48 am ESTSolicitation (Original)